Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Scholar Rock Holding sell Fitzi

Start price
€23.40
10.10.24 / 0%
Target price
-
10.10.25
Performance (%)
45.30%
End price
€34.00
11.10.25
Summary
This prediction ended on 11.10.25 with a price of €34.00. The SELL prediction by Fitzi for Scholar Rock Holding was trending in the completely wrong direction and closed with a performance of 45.30%. This prediction was marked as speculative and is excluded from Fitzi's performance statistics.

Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.

Performance without dividends (%)
Name 1w 1m 1y
Scholar Rock Holding 3.093% 3.093% 0.503%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Fitzi for this prediction

In the thread Scholar Rock Holding diskutieren

Sell Scholar Rock Holding

In the thread Trading Scholar Rock Holding
Prediction Sell
Perf. (%) 45.30%
Target price
Change
Ends at 10.10.25

Die von Fitzi gewählte maximale Laufzeit wurde überschritten